Dr. Chapa’s Clinical Pearls. ⭐️NEW⭐️Clinical Practice Update: ACOG Updates PB 222 (Biomarkers for PreE).
Apr 4, 2024
The podcast delves into the recent FDA approval of a biomarker test for preeclampsia risk in pregnant women with hypertension. It discusses the significance of biomarkers like plGF and sFLT1 and their predictive value for severe preeclampsia. The update provides insights on interpreting the FDA-approved test and addresses cultural beliefs in pregnancy assessment, emphasizing the complementary role of risk stratification tools in diagnosis.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Significance of Biomarkers in Predicting Preeclampsia Risk
01:45 • 4min
Clinical Practice Update: Interpretation of FDA-Approved Test for Hypertensive Disorders of Pregnancy
06:13 • 2min
Clinical Practice Updates and Cultural Beliefs in Pregnancy Assessment
08:29 • 11min
Complementary Risk Stratification Tool for Preeclampsia Diagnosis
19:41 • 6min